MedPath

Combined Hormonal Contraceptive Use in High Risk Women: A Longitudinal Study

Completed
Conditions
Pregnancy
Registration Number
NCT00361400
Lead Sponsor
University of California, San Francisco
Brief Summary

This study is an examination of "high risk" young women, 15-24 years of age, who initiate first time use of vaginal ring, oral contraceptives, contraceptive path, or Depo-provera.

Detailed Description

Approximately 1600 young women will be enrolled in a 12 month, observation study of their contraceptive use. They will complete surveys at baseline, 3, 6 and 12 months. They will also undergo pregnancy testing at baseline, 6 and 12 month visits. The study is examining such things are the relationship between partnerships, parental and peer influences, and contraceptive choice; Factors associated with long term continuation of contraceptive methods; Attributes of new hormonal contraceptive associated with user satisfaction and long-term continuation; And the extent to which high-risk women who use these methods are also condom users and determine the characteristics of these users.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
1387
Inclusion Criteria
  • 15-24 years old, English or spanish speaking, Starting ring, pill, patch, or Depo for first time, Sexually active, Single, Not pregnant, Living in Bay Area for next 12 months
Exclusion Criteria

Past user of method, Married, Pregnant, Moving out of area, Not sexually active

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (3)

Planned Parenthood - Shasta Diablo

🇺🇸

Vallejo, California, United States

Planned Parenthood-Golden Gate

🇺🇸

Oakland, California, United States

University of California, San Francisco

🇺🇸

San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath